Our publications related to cancer biomarkers

Found 7 results
Filters: First Letter Of Last Name is M  [Clear All Filters]
Journal Article
Menyhart O, Budczies J, Munkácsy G, Esteva FJ, Szabó A, Miquel TP, Győrffy B.  2017.  DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer. Oncotarget. 8(44):77207-77218.
Menyhart O, Budczies J, Munkácsy G, Esteva FJ, Szabó A, Miquel TP, Győrffy B.  2017.  DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer. Oncotarget. 8(44):77207-77218.
Menyhart O, Budczies J, Munkácsy G, Esteva FJ, Szabó A, Miquel TP, Győrffy B.  2017.  DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer. Oncotarget. 8(44):77207-77218.
Győrffy B, Karn T, Sztupinszki Z, Weltz B, Müller V, Pusztai L.  2015.  Dynamic classification using case-specific training cohorts outperforms static gene expression signatures in breast cancer.. Int J Cancer. 136(9):2091-8.
Gyorffy B., Molnar B., Lage H., Szallasi Z., Eklund A.C.  2009.  Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples. PLoS One. 4:e5645.
Mihály Z, Kormos M, Lánczky A, Dank M, Budczies J, Szász MA, Győrffy B.  2013.  A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer.. Breast Cancer Res Treat. 140(2):219-32.
Lánczky A, Nagy Á, Bottai G, Munkácsy G, Szabó A, Santarpia L, Győrffy B.  2016.  miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Res Treat. 160(3):446.